Skip to main content
An older man seated on a stool, flanked by two younger individuals standing, all posing for a portrait against a dark background.

NF affects 1 in every 2,000 births

NF refers to genetic conditions that cause tumors to grow on nerves throughout the body. NF includes all forms of neurofibromatosis and schwannomatosis and affects about 4 million people worldwide. Anyone can be born with NF, and it affects everyone differently. There is no cure yet.

1

FDA-approved Drug for NF, and more on the horizon

Koselugo (selumetinib) is the first FDA-approved drug for NF. CTF-funded research paved the way to this drug approval, and we are working for more approved drugs for all types of NF!

3X

the number of NF Clinical Trials in the past 10 years

There are currently 67 active clinical trials for NF – three times the number of trials than just ten years ago!

45

years of funding NF research

The Children’s Tumor Foundation was founded 45 years ago as the first grassroots organization to support patients with all types of NF.

11,000

have joined the NF Registry

The NF Registry is a secure website where people with NF can take an active role in the search for better treatments. Participating is easy and makes a difference!

20,000

patients each year visit the NF Clinic Network

The NF Clinic Network (NFCN) is the first nationwide network dedicated to improving clinical care and establishing best practices for treating individuals with NF.

Learn More about

NF1

Neurofibromatosis type 1

Learn More about

NF2-SWN

NF2-related schwannomatosis

Learn More about

SWN

Schwannomatosis

CTF Knowledge Base

Find a Doctor

Search our database for an NF specialist near you

Types of NF

Learn more about NF1, and all types of SWN, including NF2-SWN

A young boy blowing bubbles on the grass.

Share Your Story

Tell us more about your NF journey

Find an Event

Signup or donate to a CTF fundraising event

Search for a Volunteer

Search for a participant or fundraising team

Donate

Your gifts make a difference

Man at podium speaking

The NF Conference

Learn more about the largest annual gathering of NF experts

women in lap viewing sample

CTF Grant Giving

View upcoming RFAs and search CTF-funded projects

test tubes

Pharma and Biotech Partners

Read about our Pharma and Biotech partnerships

What are you looking for?

Search our website for news and information about NF. 

Latest News

Chicago Tribune logo on a blue background with white geometric lines and dots.
CTF in the News

CEO Annette Bakker Opinion Piece Published in Chicago Tribune

The Chicago Tribune published Children's Tumor Foundation CEO Annette Bakker's most recent editorial on patient…
A circular logo on a blue background featuring a raised hand with the text "Natural History Study of CNF in NF1" around it.
Featured

Natural History Study of Cutaneous Neurofibromas in People with Neurofibromatosis Type 1 (NF1)

A natural history study of cutaneous neurofibromas in people with Neurofibromatosis Type 1 (NF1) is…
Featured

Welcome Dariusz Adamczewski as Managing Director of Children’s Tumor Foundation Europe

We are pleased to announce that Dariusz Adamczewski has joined Children's Tumor Foundation (CTF) Europe…
A researcher typing on a keyboard in a lab with a microscope and computer screens displaying cell images, titled "using the nf registry in research.
Featured

Using the NF Registry in Research: Video

The NF Registry represents the collaborative efforts of patients from around the world diagnosed with…
Two individuals standing in front of a banner for the "ASGCT 2024 Annual Meeting" in Baltimore, smiling at the camera.
Awards & Grants

CTF Featured at American Society of Gene & Cell Therapy Annual Meeting

Samantha Ginn and Vidya Browder The Children's Tumor Foundation (CTF) had its partnership with the…
Group of people celebrating at the New York Stock Exchange for the Children's Tumor Foundation event.
Awareness

CTF Rings The Opening Bell® at the New York Stock Exchange

https://youtu.be/Quxaf58bjmM Today, we ring the bell for PATIENTS, for PROGRESS, and for POSSIBILITY. We ring…
Graphical abstract from The New England Journal of Medicine showing the effects of Brigatinib in NF2-related Schwannomatosis, indicating a decrease in tumor volume for various target tumors.
Collaborations & Partnerships

Brigatinib Shows Promise for NF2-SWN: A Direct Result of CTF’s Synodos Initiative

A landmark study published in the New England Journal of Medicine has revealed promising results…
Chicago Tribune logo on a blue background with white geometric lines and dots.
CTF in the News

CEO Annette Bakker Opinion Piece Published in Chicago Tribune

The Chicago Tribune published Children's Tumor Foundation CEO Annette Bakker's most recent editorial on patient…
A circular logo on a blue background featuring a raised hand with the text "Natural History Study of CNF in NF1" around it.
Featured

Natural History Study of Cutaneous Neurofibromas in People with Neurofibromatosis Type 1 (NF1)

A natural history study of cutaneous neurofibromas in people with Neurofibromatosis Type 1 (NF1) is…
Featured

Welcome Dariusz Adamczewski as Managing Director of Children’s Tumor Foundation Europe

We are pleased to announce that Dariusz Adamczewski has joined Children's Tumor Foundation (CTF) Europe…
Awareness

Global Landmarks Illuminate for World NF Awareness Day as Children’s Tumor Foundation Highlights its Make NF Research Visible Campaign

Hundreds of sites worldwide light up blue and green to raise awareness of neurofibromatosis and…
A researcher typing on a keyboard in a lab with a microscope and computer screens displaying cell images, titled "using the nf registry in research.
Featured

Using the NF Registry in Research: Video

The NF Registry represents the collaborative efforts of patients from around the world diagnosed with…
Two individuals standing in front of a banner for the "ASGCT 2024 Annual Meeting" in Baltimore, smiling at the camera.
Awards & Grants

CTF Featured at American Society of Gene & Cell Therapy Annual Meeting

Samantha Ginn and Vidya Browder The Children's Tumor Foundation (CTF) had its partnership with the…
Group of people celebrating at the New York Stock Exchange for the Children's Tumor Foundation event.
Awareness

CTF Rings The Opening Bell® at the New York Stock Exchange

https://youtu.be/Quxaf58bjmM Today, we ring the bell for PATIENTS, for PROGRESS, and for POSSIBILITY. We ring…

Stay Up-To-Date

Join our mailing list for news, exclusive resources, events and opportunities.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.